Skip to main content
SpringerLink
Log in

Quadrivalent influenza vaccine cost effective in Germany

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 euros

Reference

  • Dolk C, et al. Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. PharmacoEconomics : 19 Sep 2016. Available from: URL: http://dx.doi.org/10.1007/s40273-016-0443-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Quadrivalent influenza vaccine cost effective in Germany. PharmacoEcon Outcomes News 762, 32 (2016). https://doi.org/10.1007/s40274-016-3408-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3408-3

Search

Navigation